| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Dihydroquercetin | Asthma | 1 | PM | 35000533 | 📋 | Taxifolin improves inflammatory injury of human bronchial epithelial cells by inhibiting matrix metalloproteinase (MMP) 10 via Wnt/β-catenin pathway |
| Dihydroquercetin | Psoriasis | 2 | PM | 34233233 | 📋 | Taxifolin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like mouse model via regulating cytoplasmic phospholipase A2 and PPAR-γ pathway |
| Dihydroquercetin | Psoriasis | 1 | PM | 31881484 | 📋 | Taxifolin attenuates IMQ-induced murine psoriasis-like dermatitis by regulating T helper cell responses via Notch1 and JAK2/STAT3 signal pathways |
| Dihydroquercetin | Rheumatoid Arthritis | 1 | PM | 30522105 | 📋 | Taxifolin Inhibits Receptor Activator of NF-κB Ligand-Induced Osteoclastogenesis of Human Bone Marrow-Derived Macrophages in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo |
| Dihydroquercetin | Ulcerative Colitis | 1 | PM | 35268045 | 📋 | Taxifolin Alleviates DSS-Induced Ulcerative Colitis by Acting on Gut Microbiome to Produce Butyric Acid |
